Related references
Note: Only part of the references are listed.Multiscale modelling in immunology: a review
Antonio Cappuccio et al.
BRIEFINGS IN BIOINFORMATICS (2016)
Optimal Dosing for Targeted Therapies in Oncology: Drug Development Cases Leading by Example
Jeffrey R. Sachs et al.
CLINICAL CANCER RESEARCH (2016)
Tissue constructs: platforms for basic research and drug discovery
Elliot L. Elson et al.
INTERFACE FOCUS (2016)
Radiomics: Images Are More than Pictures, They Are Data
Robert J. Gillies et al.
RADIOLOGY (2016)
Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and Documentation
S. F. Marshall et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2016)
Toward a Science of Tumor Forecasting for Clinical Oncology
Thomas E. Yankeelov et al.
CANCER RESEARCH (2015)
Impact of Metabolic Heterogeneity on Tumor Growth, Invasion, and Treatment Outcomes
M. Robertson-Tessi et al.
CANCER RESEARCH (2015)
Physiologically Based Pharmacokinetic Modeling in Drug Discovery and Development: A Pharmaceutical Industry Perspective
H. M. Jones et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Role of Chemical Reactivity and Transition State Modeling for Virtual Screening
Muthukumarasamy Karthikeyan et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2015)
Computational systems biology approaches to anti-angiogenic cancer therapeutics
Stacey D. Finley et al.
DRUG DISCOVERY TODAY (2015)
Targeting cancer with kinase inhibitors
Stefan Gross et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
An agent-based modeling framework linking inflammation and cancer using evolutionary principles: Description of a generative hierarchy for the hallmarks of cancer and developing a bridge between mechanism and epidemiological data
Gary An et al.
MATHEMATICAL BIOSCIENCES (2015)
Simulating cancer growth with multiscale agent-based modeling
Zhihui Wang et al.
SEMINARS IN CANCER BIOLOGY (2015)
A Multiscale Model Evaluates Screening for Neoplasia in Barrett's Esophagus
Kit Curtius et al.
PLOS COMPUTATIONAL BIOLOGY (2015)
Site-Specific Phosphorylation of VEGFR2 Is Mediated by Receptor Trafficking: Insights from a Computational Model
Lindsay Wendel Clegg et al.
PLOS COMPUTATIONAL BIOLOGY (2015)
Systems pharmacology approaches for optimization of antiangiogenic therapies: challenges and opportunities
Satish Sharan et al.
FRONTIERS IN PHARMACOLOGY (2015)
Optimizing Oncology Therapeutics Through Quantitative Translational and Clinical Pharmacology: Challenges and Opportunities
K. Venkatakrishnan et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Strategies of Eradicating Glioma Cells: A Multi-Scale Mathematical Model with miR-451-AMPK-mTOR Control
Yangjin Kim et al.
PLOS ONE (2015)
Characterization of p38 MAPK isoforms for drug resistance study using systems biology approach
Huiming Peng et al.
BIOINFORMATICS (2014)
Cardiac Tissue Engineering State of the Art
Marc N. Hirt et al.
CIRCULATION RESEARCH (2014)
Assessment of Tumor Growth Inhibition Metrics to Predict Overall Survival
L. Claret et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Network Pharmacology Strategies Toward Multi-Target Anticancer Therapies: From Computational Models to Experimental Design Principles
Jing Tang et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Determining the optimal dose in the development of anticancer agents
Ron H. J. Mathijssen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Quantitative multimodality imaging in cancer research and therapy
Thomas E. Yankeelov et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Targeting the Biophysical Properties of the Myeloma Initiating Cell Niches: A Pharmaceutical Synergism Analysis Using Multi-Scale Agent-Based Modeling
Jing Su et al.
PLOS ONE (2014)
Global Dormancy of Metastases Due to Systemic Inhibition of Angiogenesis
Sebastien Benzekry et al.
PLOS ONE (2014)
The Anomalous Diffusion of a Tumor Invading with Different Surrounding Tissues
Chongming Jiang et al.
PLOS ONE (2014)
Timing and heterogeneity of mutations associated with drug resistance in metastatic cancers
Ivana Bozic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Implementation of Quantitative and Systems Pharmacology in Large Pharma
S. A. G. Visser et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2014)
Basic Concepts in Population Modeling, Simulation, and Model-Based Drug Development: Part 3-Introduction to Pharmacodynamic Modeling Methods
R. N. Upton et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2014)
POPULATIONAL ADAPTIVE EVOLUTION, CHEMOTHERAPEUTIC RESISTANCE AND MULTIPLE ANTI-CANCER THERAPIES
Alexander Lorz et al.
ESAIM-MATHEMATICAL MODELLING AND NUMERICAL ANALYSIS-MODELISATION MATHEMATIQUE ET ANALYSE NUMERIQUE (2013)
Effect of Tumor Microenvironment on Tumor VEGF During Anti-VEGF Treatment: Systems Biology Predictions
Stacey D. Finley et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
A mechanically coupled reaction-diffusion model for predicting the response of breast tumors to neoadjuvant chemotherapy
Jared A. Weis et al.
PHYSICS IN MEDICINE AND BIOLOGY (2013)
Systematically Studying Kinase Inhibitor Induced Signaling Network Signatures by Integrating Both Therapeutic and Side Effects
Hongwei Shao et al.
PLOS ONE (2013)
Defining principles of combination drug mechanisms of action
Justin R. Pritchard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Computational Modeling of ERBB2-Amplified Breast Cancer Identifies Combined ErbB2/3 Blockade as Superior to the Combination of MEK and AKT Inhibitors
Daniel C. Kirouac et al.
SCIENCE SIGNALING (2013)
Clinically Relevant Modeling of Tumor Growth and Treatment Response
Thomas E. Yankeelov et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Evolution of intratumoral phenotypic heterogeneity: the role of trait inheritance
Jill Gallaher et al.
INTERFACE FOCUS (2013)
Systems Modeling of Anti-apoptotic Pathways in Prostate Cancer: Psychological Stress Triggers a Synergism Pattern Switch in Drug Combination Therapy
Xiaoqiang Sun et al.
PLOS COMPUTATIONAL BIOLOGY (2013)
Covariate Pharmacokinetic Model Building in Oncology and its Potential Clinical Relevance
Markus Joerger
AAPS JOURNAL (2012)
Multiscale Models of Breast Cancer Progression
Anirikh Chakrabarti et al.
ANNALS OF BIOMEDICAL ENGINEERING (2012)
Cytokine combination therapy prediction for bone remodeling in tissue engineering based on the intracellular signaling pathway
Xiaoqiang Sun et al.
BIOMATERIALS (2012)
Fundamentals of Population Pharmacokinetic Modelling
Catherine M. T. Sherwin et al.
CLINICAL PHARMACOKINETICS (2012)
Fundamentals of Population Pharmacokinetic Modelling
Tony K. L. Kiang et al.
CLINICAL PHARMACOKINETICS (2012)
Cellular modeling of cancer invasion: Integration of in silico and in vitro approaches
Yoonseok Kam et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Patient-calibrated agent-based modelling of ductal carcinoma in situ (DCIS): From microscopic measurements to macroscopic predictions of clinical progression
Paul Macklin et al.
JOURNAL OF THEORETICAL BIOLOGY (2012)
A systematic modeling study on the pathogenic role of p38 MAPK activation in myelodysplastic syndromes
Huiming Peng et al.
MOLECULAR BIOSYSTEMS (2012)
SYSTEM IDENTIFICATION IN TUMOR GROWTH MODELING USING SEMI-EMPIRICAL EIGENFUNCTIONS
Thierry Colin et al.
MATHEMATICAL MODELS & METHODS IN APPLIED SCIENCES (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Integrating Intracellular Dynamics Using CompuCell3D and Bionetsolver: Applications to Multiscale Modelling of Cancer Cell Growth and Invasion
Vivi Andasari et al.
PLOS ONE (2012)
A Study on Cheminformatics and its Applications on Modern Drug Discovery
B. Firdaus Begam et al.
INTERNATIONAL CONFERENCE ON MODELLING OPTIMIZATION AND COMPUTING (2012)
A three-dimensional in vitro ovarian cancer coculture model using a high-throughput cell patterning platform
Feng Xu et al.
BIOTECHNOLOGY JOURNAL (2011)
2011: the immune hallmarks of cancer
Federica Cavallo et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Drug Inhibition Profile Prediction for NFκB Pathway in Multiple Myeloma
Huiming Peng et al.
PLOS ONE (2011)
Rhetorical Institutionalism: Language, Agency, and Structure in Institutional Theory since Alvesson 1993
Sandy Edward Green et al.
JOURNAL OF MANAGEMENT STUDIES (2011)
The physics of cancer: the role of physical interactions and mechanical forces in metastasis
Denis Wirtz et al.
NATURE REVIEWS CANCER (2011)
Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis
Brett E. Houk et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Extrapolating glioma invasion margin in brain magnetic resonance images: Suggesting new irradiation margins
Ender Konukoglu et al.
MEDICAL IMAGE ANALYSIS (2010)
Toward a VPH/Physiome ToolKit
Alan Garny et al.
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2010)
Drug Off-Target Effects Predicted Using Structural Analysis in the Context of a Metabolic Network Model
Roger L. Chang et al.
PLOS COMPUTATIONAL BIOLOGY (2010)
Dissecting cancer through mathematics: from the cell to the animal model
Helen M. Byrne
NATURE REVIEWS CANCER (2010)
Multiscale Models of Angiogenesis
Amina A. Quitub et al.
IEEE ENGINEERING IN MEDICINE AND BIOLOGY MAGAZINE (2009)
Drug targeting and tumor heterogeneity
You Han Bae
JOURNAL OF CONTROLLED RELEASE (2009)
Multiscale Modeling of Form and Function
Adam J. Engler et al.
SCIENCE (2009)
Therapeutically Targeting ErbB3: A Key Node in Ligand-Induced Activation of the ErbB Receptor-PI3K Axis
Birgit Schoeberl et al.
SCIENCE SIGNALING (2009)
Agent-based models in translational systems biology
Gary An et al.
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2009)
Drug Discovery Using Chemical Systems Biology: Identification of the Protein-Ligand Binding Network To Explain the Side Effects of CETP Inhibitors
Li Xie et al.
PLOS COMPUTATIONAL BIOLOGY (2009)
Predicting drug side-effects by chemical systems biology
Nicholas P. Tatonetti et al.
GENOME BIOLOGY (2009)
Essential operating principles for tumor spheroid growth
Jesse A. Engelberg et al.
BMC SYSTEMS BIOLOGY (2008)
Development of translational pharmacokinetic-pharmacodynamic models
D. E. Mager et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Pharmacometrics: A multidisciplinary field to facilitate critical thinking in drug development and translational research settings
Jeffrey S. Barrett et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Network pharmacology: the next paradigm in drug discovery
Andrew L. Hopkins
NATURE CHEMICAL BIOLOGY (2008)
Age-specific incidence of cancer: Phases, transitions, and biological implications
Rafael Meza et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
An age-and-cyclin-structured cell population model for healthy and tumoral tissues
Fadia Bekkal Brikci et al.
JOURNAL OF MATHEMATICAL BIOLOGY (2008)
A mathematical modelling tool for predicting survival of individual patients following resection of glioblastoma: a proof of principle
K. R. Swanson et al.
BRITISH JOURNAL OF CANCER (2008)
Model-based drug development
R. L. Lalonde et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Systems biology and combination therapy in the quest for clinical efficacy
Jonathan B. Fitzgerald et al.
NATURE CHEMICAL BIOLOGY (2006)
Mathematical methods and tools of kinetic theory towards modelling complex biological systems
A Bellouquid et al.
MATHEMATICAL MODELS & METHODS IN APPLIED SCIENCES (2005)
A hybrid mathematical model of solid tumour invasion: the importance of cell adhesion
ARA Anderson
MATHEMATICAL MEDICINE AND BIOLOGY-A JOURNAL OF THE IMA (2005)
Multistage carcinogenesis and the incidence of colorectal cancer
EG Luebeck et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
On the closure of mass balance models for tumor growth
D Ambrosi et al.
MATHEMATICAL MODELS & METHODS IN APPLIED SCIENCES (2002)
Pharmacokinetics and its role in small molecule drug discovery research
GR Jang et al.
MEDICINAL RESEARCH REVIEWS (2001)
Share Paper
